- Report
- June 2024
- 137 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- May 2024
- 137 Pages
United States
From €5656EUR$5,950USD£4,752GBP
- Report
- April 2023
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Book
- April 2018
- 224 Pages
- Book
- July 2024
North America
- Book
- April 2022
North America

Osteoarthritis is a degenerative joint disease that affects the cartilage, bones, and other tissues of the joints. It is the most common form of arthritis and is characterized by pain, stiffness, and swelling in the affected joints. The disease is caused by the breakdown of cartilage, which is the cushioning material between the bones in the joint. As the cartilage wears away, the bones rub against each other, causing pain and inflammation. Osteoarthritis can affect any joint in the body, but it is most common in the hands, hips, knees, and spine.
The osteoarthritis market is composed of a variety of products and services designed to help manage the symptoms of the disease. These include medications, physical therapy, and assistive devices such as braces and splints. In addition, there are a number of surgical procedures available to treat the condition, such as joint replacement and arthroscopy.
Companies in the osteoarthritis market include pharmaceutical companies such as Pfizer and Merck, medical device companies such as Zimmer Biomet and Stryker, and physical therapy providers such as Physiotherapy Associates and Select Physical Therapy. Show Less Read more